Nasdaq ends 12-day run of gains; Dow, S&P 500 rise
July 25th, 2009
| Tags: microsoft corp, pharmaceuticals, product transition, quarterly revenue, second quarter earnings
By Ellis Mnyandu NEW YORK (Reuters) - The Nasdaq fell on Friday, halting a 12-day run-up, following Microsoft Corp’s (MSFT.O) disappointing quarterly results, but gains in pharmaceutical and energy shares lifted the Dow and the S&P 500 to fresh 8-month closing highs. Microsoft shares slid 8.3 percent to $23.45, a day after the software maker posted quarterly revenue below Wall Street’s estimates. Web retailer Amazon.com Inc (AMZN.O) also missed sales expectations, driving its stock down 7.9 percent to $86.49. The results cast a cloud over what is so far shaping up to be a stronger-than-expected second-quarter earnings season. Even so, investors took Wall Street’s initial drop on Friday as an opportunity to scoop up shares in other sectors, including energy and defensive plays such as big pharmaceuticals and utilities. “Microsoft is going through a product transition and no great visibility on the Windows franchise, but in general, the tone this quarter for a good many companies has been strong,” said Owen Fitzpatrick, head of the U.[...]
Related videos from
YouTube
:
- Pharmaceuticals and ToxinsAll drugs come with side effects, and there are many other toxins in the world our dogs may have access to. So many pharmaceutical drugs have natural alternatives without the side effects but are just as effective. To see more topics and a menu for our clips please visit www.canine-health-concern.org.uk/videolibrary.htmlWallstrip - Onyx Pharmaceuticals, Inc. (ONXX)Wallstrip - Onyx Pharmaceuticals, Inc. (ONXX)(12-4-07) Is life worth living? That depends on the liver... and Onyx Pharmaceuticals, Inc. (ONXX).Products Liability Law and Pharmaceuticals: Matthew Shors of O'Melveny & MyersProducts Liability Law and Pharmaceuticals: Matthew Shors of O'Melveny & MyersMatthew Shors of omelveny & Myers in Washington, DC, addresses the topic of "Products Liability Law and Pharmaceuticals" on a panel at the Northwestern Law Judicial Education Program's "Judicial Symposium on The Pharmaceutical Industry: Economics, Regulation, and Legal Issues", held in May 2009.Pharmaceuticals are the leading cause of death!Pharmaceuticals are the leading cause of death!
- Organic Reactions and Pharmaceuticals, Lec 2, Chemistry 14D, UCLACourse Description: Chemistry 14D: Organic Reactions and Pharmaceuticals is a class that provides an in depth analysis of organic reactions, nucleophilic and electrophilic substitutions and additions; electrophilic aromatic substitutions, carbonyl reactions, catalysis, molecular basis of drug action, and organic chemistry of pharmaceuticals. About the Professor: Professor Hardinger has been a faculty member in the UCLA Department of Chemistry and Biochemistry since 1997. His professional career began at Drexel University in Philadelphia, which afforded a BS in Chemistry in 1982. He then moved to Purdue University, and earned a phd in Organic Chemistry in 1988. Two subsequent years as a postdoctoral scholar at Renssalear Polytechnic Institute were followed by appointment in 1990 as assistant professor at California State University. In 1997 he achieved the "forbidden transition" and moved to UCLA as Lecturer followed by promotion to Senior Lecturer in 2004. At UCLA his main teaching interests have been introductory organic chemistry courses in the physical science majors series as well as the life science majors series. His professional interests include development of new teaching tools and methods, both in print and electronic media. An introductory organic chemistry textbook (Organic Chemistry - A Thinking Student's Approach) is currently in development. Course Webpage: www.chem.ucla.eduNote: Some clips and images may have been blurred or removed to avoid copyright ...Products Liability Law and Pharmaceuticals:Katharine R. Latimer, Hollingsworth LLPKatharine R. Latimer of Hollingsworth LLP, Washington, DC, addresses the topic of "Products Liability Law and Pharmaceuticals" on a panel at the Northwestern Law Judicial Education Program's "Judicial Symposium on The Pharmaceutical Industry: Economics, Regulation, and Legal Issues", held in May 2009.Pharmaceuticals in waterAn Associated Press investigation found pharmaceuticals in nearly ever drinking water supply that they tested.Array of Pharmaceuticals in US Water Supply Part 1"Anti-Epileptics, Sex Hormones, Mood Stabilizers, Antibiotics Among Array of Pharmaceuticals in US Water Supply" Flash player of entire broadcasts now available at: www.democracynow.org "Anti-epileptics were found in the drinking water of Southern California; a sex hormone was found in San Francisco's water; three medications and an antibiotic were found in the water supply of Tuscon, Arizona; and a mood stabilizer was found in the water of New Jersey. And that's just to name a few. An exhaustive five-month investigation by Associated Press has found the drinking water in at least twenty-four major American cities across the country contains trace amounts of a wide array of pharmaceuticals. We speak with Associated Press national writer, Jeff Donn." httpLeave a commentNo comments yet.
